Biotech | November 26, 2021
Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Owkin builds best-in-class predictive biomedical AI models and robust data sets
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
Subscribe To Our Newsletter & Stay Updated
